Firm's vision is to harness power of microorganisms as a sustainable platform to produce proteins now derived from animals ...
Travere Therapeutics Stock (TVTX) is plummeting on news of a potential FDA delay for its kidney disease treatment ...
The U.S. Food and Drug Administration approved Fortress Biotech and Indian drugmaker Zydus Lifesciences' drug for children ...
At a STAT event, veteran drug regulator Richard Pazdur, who left the FDA last month after 26 years, said that politics and ...
It was the priciest biotech startup sale in North Carolina history. Now five years under Bayer, AskBio advances more AAV gene ...
Rare Pediatric Disease Priority Review Voucher (PRV) granted by FDA at approval to be transferred from Sentynl Therapeutics ...
Rare Pediatric Disease Priority Review Voucher (PRV) granted by FDA at approval to be transferred from Sentynl Therapeutics to Cyprium Cyprium eligible to receive tiered royalties and up to $129 milli ...
Investor's Business Daily on MSN
IBD stock of the day Medpace tests early buy point as biotech funding shines
Medpace Holdings is Tuesday's IBD Stock Of The Day. Shares are testing an early entry as the biotech funding environment ...
Leading event to bridge research, clinical adoption, and investment in microbiome-enabled health hosted by CE-Ventures, the ...
Milestone Pharmaceuticals, a Canadian company with a U.S. subsidiary in Charlotte, is starting the new year with its first approved drug. The company received notice from the U.S. Food and Drug ...
Renewal marks over a decade of Halal compliance, securing critical supply chains for biopharmaceutical growth markets through 2026 and ...
Investor's Business Daily on MSN
Stock market today: Dow sinks as investors digest inflation data; Moderna soars (live coverage)
Caterpillar CAT stock rose toward closing with a market cap of more than $300 billion for the first time ever, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback